CHRONIC KIDNEY DISEASE
Study to Evaluate the Efficacy, Safety and Tolerability of Balcinrenone in Combination with Dapagliflozin Compared with Dapagliflozin in Patients with Chronic Kidney Disease and Albuminuria.
Inclusion Criteria:
- Participant male or female must be ≥ 18 years old
- Capable of giving signed informed consent
- Diagnosis of CKD and eGFR ≥ 25 to < 60 mL/min/1.73 m2
More Information call us: 786-772-0510
